Alumni raised $1.45B in 2022 - Download Free Report Now

OsteoGeneX (aka OGX)

Small molecule oral therapeutic that combats osteoporosis and builds bone by inhibiting the activity of the Sclerostin protein.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of OsteoGeneX (aka OGX) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About OsteoGeneX (aka OGX)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With